Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered question first ministerially corrected answering member label attachment file name file name title title previous answer version answering member printed answering member label
tabling member	label

Search

1125506

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV.
	tabling member printed	Baroness Masham of Ilton
	uin	HL15601
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Public Health England, in partnership with NHS England and the Department, is taking steps to improve vaccination coverage in England, including for people living with HIV.</p><p>These steps include initiatives to improve access to the immunisation programme; communication with the public; data to identify underserved individuals and populations; and training for healthcare professionals, changes to vaccination eligibility criteria; launching disease elimination strategies; running targeted social media campaigns; providing information leaflets in multiple languages and running e-learning programme for healthcare practitioners.</p><p>Certain vaccines are delivered through sexual health services that particularly benefit people living with HIV. This includes vaccines for hepatitis A, hepatitis B and human papillomavirus. People living with HIV are in the influenza risk groups and are invited for the flu vaccine on an annual basis.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:50:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1850 label Biography information for Baroness Masham of Ilton

1125517

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Migrant Workers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of NHS staff recruited from EU member states after Brexit.
	tabling member printed	Lord Taylor of Warwick
	uin	HL15612
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The Government recognises the need to be able to recruit effectively from abroad and the Immigration White Paper, <em>The UK’s future skills-based immigration system</em>, published in December 2018, sets out the foundation for a single immigration system, where it is workers’ skills that matter, not where they come from. This system will streamline the high-skilled visa route, by removing the Resident Labour Market Test and the Tier 2 Visa Cap. The Home Office is undertaking a programme of engagement to discuss the proposed measures with colleagues across Government and industry, to develop a future immigration system that works for the whole of the United Kingdom.</p><p>The Government wants to support the National Health Service in expanding international recruitment more widely, as this clearly has a role to play to meeting staffing shortages, especially in the short term. Recruitment of doctors and nurses is the responsibility of individual NHS organisations, a number of which do actively recruit from overseas, including from countries in the European Union. However, we also recognise the need to boost our domestic workforce as well. The NHS Long Term Plan sets out a vital strategic framework to ensure that, over the next 10 years, the NHS will have the staff it needs so that nurses and doctors are working in a supportive culture that allows them to provide the expert compassionate care they are committed to providing. Details of this will be explored more fully in the forthcoming Interim NHS People Plan.</p><p>The Government has taken steps to ensure that EU citizens can continue to come and work in the NHS once we have left the EU. In March 2019, we put in place legislation that ensures the continued recognition of qualifications from EU countries by all professional regulators covering the health and social care sectors. This means that EU citizens will continue to be able to come and practice in the UK once we have left the EU, even if we leave without a deal.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:54:38 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1796 label Biography information for Lord Taylor of Warwick

1125835

	registered interest
	date	09/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Health: Antibiotics
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 4 December 2018 (HL11750), how many antibiotic prescriptions were issued by general dental practitioners in England in 2018.
	tabling member printed	Lord Colwyn
	uin	HL15625
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The Dental Prescribing Dashboard developed by the NHS Business Services Authority and Public Health England, includes data for National Health Service local area teams. Latest available data show general dental practitioners issued 2,912,579 prescriptions for all antimicrobials including antibiotics during April 2017 to March 2018. There were 715,545 prescriptions between January and March 2018. The Dental Prescribing Dashboard will be refreshed in summer 2019.</p><p>Analysis is based on items prescribed by NHS dentists, but some patients may attend a general medical practice with a dental infection and receive a prescription from their general practitioner (GP). These prescriptions are not included, as we cannot determine the reason why a GP prescribed antibiotics.</p><p>The <em>English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018</em> provides information on NHS dental prescribing in dental practices and consultations. The ESPAUR report for 2019 scheduled for publication later this year will publish data for the 2018 calendar year. The ESPAUR 2018 report is attached.</p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:52:22 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name ESPAUR_2018_report.pdf title ESPAUR_2018_report
	tabling member	3394 label Biography information for Lord Colwyn

1126321

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gender Dysphoria: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
	tabling member printed	Lord Lucas
	uin	HL15681
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1879 label Biography information for Lord Lucas

1127014

	registered interest
	date	15/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tobacco: Retail Trade
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is their assessment of the paper Impact of a ban on the open display of tobacco products in retail outlets on never smoking youth in the UK: findings from a repeat cross-sectional survey before, during and after implementation, published in the British Medical Journal in May; and whether they will consider the implications of those findings for other unhealthy commodity industries, including gambling.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL15775
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Government keeps all such evidence on the impact of its policies under review, including the possible wider application of individual policies to other areas. The Government intends to conduct a formal post-implementation review of this legislation with a report due in spring 2020 and evidence of this nature will be looked at to assess the overall impact of legislation. There are no plans to extend the current ban on open display of tobacco products in retail outlets to other products.</p> answering member printed Baroness Blackwood of North Oxford question first answered 24/05/2019 11:48:27 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4308 label Biography information for The Lord Bishop of St Albans

1127421

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bacterial Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 14 May (HL15384), what assessment they have made of the number of people, with or without resistant blood stream infections, who have Carbapenem resistant E. coli-like bacteria present in their bodies; and what (1) proposed, and (2) current, initiatives there are to control the transmission of such bacteria.
	tabling member printed	Baroness Gardner of Parkes
	uin	HL15832
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>The 2018 English surveillance programme for antimicrobial utilisation and resistance report contains information on carbapenem-resistant Escherichia coli (E. coli) causing bloodstream infections in England. In 2017 there were 18 cases. The number of people with other infections and carriage of E. coli resistant to carbapenems is harder to ascertain as surveillance is not as uniform.</p><p>Public Health England (PHE) publishes guidance on the prevention and control of carbapenemase-producing Enterobacteriaceae (including E. coli); guidance is available for both acute and non-acute settings, copies of the <em>Toolkit for managing carbapenemase-producing Enterobacteriaceae in non-acute and community settings</em> and <em>Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae</em> are attached. PHE is supporting actions outlined in the United Kingdom’s Tackling Antimicrobial Resistance National Action Plan that aim to prevent and control the transmission of carbapenem-resistant bacteria, which includes reducing the number of specific drug-resistant infections in people by 10% by 2025; reducing UK antimicrobial use in humans by 15% by 2024; and adding carbapenem-resistant Gram-negative infections to the list of notifiable diseases in existing laboratory reporting systems.</p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name Acute_trust_toolkit_for_the_early_detection.pdf title Acute trust toolkit 2 file name CPE-Non-AcuteToolkit_CORE.pdf title CPE Non Acute toolkit question first answered 04/06/2019 13:45:10 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3596 label Biography information for Baroness Gardner of Parkes

1127424

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Diseases: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the potential of schemes by pharmaceutical companies to develop recycling and recovery schemes for respiratory inhalers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL15835
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>We are informed by NHS England that its joint Public Health England funded Sustainable Development Unit (SDU) has reviewed a scheme operated by GlaxoSmithKline that encourages return of inhalers for recycling. The scheme is very welcome but limited in scope, currently recovering around 1% of all inhalers.</p><p>All used inhalers can already be returned to all pharmacies to be disposed of by incineration with the medicines waste streams.</p><p>NHS England has invited industry suggestions to the national Low Carbon Inhalers Working Group established by the SDU, on ways to increase recovery for environmentally safe disposal and recycling.</p> answering member printed Baroness Blackwood of North Oxford question first answered 04/06/2019 13:46:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127427

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what discussions they intend to have, if any, with pharmaceutical companies about how the environmental damage caused by asthma inhalers may be reduced.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL15838
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>NHS England has been in regular dialogue with industry over the last 18 months about the need to reduce the environmental damage caused by asthma inhalers. As a result, an industry working group on this has been formed, chaired by the Industry Pharmaceutical Aerosol Consortium (IPAC). IPAC has now accepted an invitation to join the national Low Carbon Inhalers Working Group, chaired by the Sustainable Development Unit, to represent industry. This working group has been asked to provide proposals from industry on reducing the carbon impacts of inhalers to support the NHS Long Term Plan target.</p> answering member printed Baroness Blackwood of North Oxford question first answered 04/06/2019 13:39:39 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127428

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the sufficiency of the progress made by NICE on working with clinicians and industry to promote greater use of asthma inhalers with low global warming potential.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL15839
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) published an online only patient decision aid for inhalers used in the treatment of asthma on 8 April 2019.</p><p>The purpose of this aid is to help people with asthma and their healthcare professional to discuss the different inhaler devices that are available to treat their condition and where appropriate, to consider the environmental impact of the inhaler. The patient decision aid has been downloaded over 1,500 times since its publication.</p><p>To encourage use of the decision aid, NICE is contributing to an expert working group on sustainable inhalers led by the Sustainable Development Unit which is actively promoting this work. The working group members include clinicians and patient organisations, such as Asthma UK and the British Lung Foundation. NICE has also shared the patient decision aid through its network of NICE associates - a network of National Health Service professionals who support implementation of NICE guidance across the NHS.</p> answering member printed Baroness Blackwood of North Oxford question first answered 04/06/2019 13:42:39 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127994

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Prescriptions
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what response they have made of the report by Asthma UK Paying to breathe: Why unfair asthma prescription charges must be stopped; and whether they have responded, or intend to respond, to that report.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL15879
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>I recently met with Asthma UK and discussed their report. Departmental officials continue to engage with Asthma UK on the issues raised in the meeting.</p><p>The Government has no plans to review the current system of medical exemptions from prescription charges. Extensive arrangements are already in place to help people access National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions.</p><p>To support those with the greatest need who do not qualify for an exemption, the cost of the prescription pre-payment certificates has been frozen for another year. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 05/06/2019 14:08:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath